EU Drug Market: MDMA — References

This resource is part of EU Drug Market: MDMA — In-depth analysis by the EUDA and Europol.

Table of contents/Search

Table of contents/Search

Search within the book

Operator

Any match

Exact term match only

Select any filter and click on Search to see results

Close

Last update: March 2025

List of references

This page contains a list of references used in the publication EU Drug Market: MDMA — In-depth analysis.

Aldridge, J. and Décary-Hétu, D. (2016), ‘Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets’, International Journal of Drug Policy 35, pp. 7-15.

Bettington, E., Spinks, J., Kelly, F., Gallardo-Godoy, A., Nghiem, S. and Wheeler, A. J. (2018), ‘When is a medicine unwanted, how is it disposed, and how might safe disposal be promoted? Insights from the Australian population’, Australian Health Review 42(6), pp. 709-717.

Biniecki, S. and Krajewski, E. (1960), ‘Preparation of dl-1-(3,4-methylenedioxyphenyl)-2-(methylamino)propane and dl-(3,4-dimethoxyphenyl)-2-(methylamino)propane’, Acta Poloniae Pharmaceutica 17, pp. 421-425.

Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J. and Clausen, M. (2003), ‘A voxel-based PET investigation of the long-term effects of “Ecstasy” consumption on brain serotonin transporters’, American Journal of Psychiatry 160(7), pp. 1186-1192.

Canada Border Services Agency (2023), 'CBSA seizes over 3.3 tonnes of precursor chemicals used to make MDMA (ecstasy) and other harmful drugs', August 24.

Castrignanò, E., Yang, Z., Bade, R., Baz-Lomba, J. A., Castiglioni, S., Causanilles, A. and Kasprzyk-Hordern, B. (2018), ‘Enantiomeric profiling of chiral illicit drugs in a pan-European study’, Water Research 130, pp. 151-160.

Chambers, S. A., DeSousa, J. M., Huseman, E. D. and Townsend, S. D. (2018), ‘The DARK side of total synthesis: strategies and tactics in psychoactive drug production’, ACS Chemical Neuroscience 9(10), pp. 2307-2330.

Claessens, M., Hardyns, W., Vander Laenen, F. and Verhaeghe, N. (2019), ‘An analysis of the costs of dismantling and cleaning up synthetic drug production sites in Belgium and the Netherlands’, Background paper commissioned by the EMCDDA for the EU Drug Markets Report 2019, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.

Cole, J. C. (2014), ‘MDMA and the “ecstasy paradigm”’, Journal of Psychoactive Drugs 46(1), pp. 44-56.

Cormick, J., Carter, J. F., Currie, T., Matheson, C. and Cresswell, S. L. (2021), ‘A survey of novel MDA and MDMA precursors by isotope ratio mass spectrometry’, Forensic Chemistry 24, p. 100341.

Drug Enforcement Administration (2020), 2020 National drug threat assessment (NDTA).

Drugs Information Monitoring System (2022), 'Levensgevaarlijke MDMA vloeistof in omloop', 24 June.

Drugs Information Monitoring System (2023), 'Zeer hoog gedoseerde ecstasypillen in omloop', 8 December.

Dunlap, L. E., Andrews, A. M. and Olson, D. E. (2018), ‘Dark classics in chemical neuroscience: 3, 4-methylenedioxymethamphetamine’, ACS Chemical Neuroscience 9(10), pp. 2408-2427.

DutchNews (2022), 'Row over drugs waste clean-up bill continues as pollution spreads', DutchNewsnl, 28 February.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016), Recent changes in Europe’s MDMA/ecstasy market, EMCDDA Rapid Communication, Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2019a), Estimating the size of the main illicit retail drug markets in Europe: An update, Technical Report, Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2019b), Drug precursor developments in the European Union, EMCDDA Papers, Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2023), Spotlight on... Drug checking.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2024), European drug report 2024: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol (2017), Drugs and the darknet: Perspectives for enforcement, research and policy, Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol (2019), EU drug markets report 2019, Publications Office of the European Union, Luxembourg.

European Union Drugs Agency (EUDA) (2024), ‘Frequently asked questions (FAQ): therapeutic use of psychedelic substances’, EUDA, 30 July 2024.

Europol (2019), EU Manual on illicit synthetic drugs/NPS production, Europol, The Hague.

Europol (2021), EU serious and organised crime threat assessment, Publications Office of the European Union, Luxembourg, doi:10.2813/02362.

Foong, A. L., Grindrod, K. A., Patel, T. and Kellar, J. (2018), ‘Demystifying serotonin syndrome (or serotonin toxicity’, Canadian Family Physician 64(10), pp. 720-727.

Ford, A. (2021a), 'LatAm synthetic drug trade booming: UNODC report', InSight Crime, 2 November.

Ford, A. (2021b), 'Brazil’s Santa Catarina becoming country’s MDMA hub', Insight Crime, 28 September.

Gremeaux, L. (2022), ‘Complexity and differentiation of the MDMA retail market: Insights from the European Web Survey on Drugs’, Monitoring drug use in the digital age: Studies in web surveys, EMCDDA Insights.

Groenen, M., Spaans, G. W., Vis, S. L. and Lasaroms, J. J. P. (2023), Inventarisatie drugsdumpingen en risico’s voor voedselveiligheid, Wageningen Food Safety Research, Wageningen.

Guardia Civil (2022), 'La Guardia Civil desarticula una importante organización criminal en Ibiza e interviene la mayor cantidad de cocaína rosa aprehendida en España', 30 August.

Guirguis, K. (2010), ‘Medications collected for disposal by outreach pharmacists in Australia’, Pharmacy World & Science 32(1), pp. 52-58.

Jia, H. (2007), ‘Chinese manufacturers vie for piece of outsourcing pie’, Nature Biotechnology 25, pp. 1337-1338, doi:10.1038/nbt1207-1337.

Joachems, W. J. (2023), 'Enorme drugsafvalput lijkt nu op een bouwput van een wolkenkrabber’', Omroep Brabant, 30 November.

Kalant, H. (2001), ‘The pharmacology and toxicology of “ecstasy”(MDMA) and related drugs’, CMAJ 165(7), pp. 917-928.

Liechti, M. E. (2003), ‘Clinical pharmacology of MDMA and its analogues’, Journal of Clinical Psychopharmacology 23(2), pp. 104-110.

Liechti, M. E., Gamma, A. and Vollenweider, F. X. (2001), ‘Gender differences in the subjective effects of MDMA’, Psychopharmacology 154(2), pp. 161-168.

Losacker, M., Zörntlein, S., Schwarze, B., Staudt, S., Röhrich, J. and Hess, C. (2022), ‘Determination of the enantiomeric composition of amphetamine, methamphetamine and 3, 4‐methylendioxy‐N‐methylamphetamine (MDMA) in seized street drug samples from southern Germany’, Drug Testing and Analysis 14(3), pp. 557-566.

Makunts, T., Jerome, L., Abagyan, R. and Boer, A. (2022), ‘Reported cases of serotonin syndrome in MDMA users in FAERS database’, Frontiers in Psychiatry 12, p. 824288.

Merck, E. (1914), 'Verfahren zur Darstellung von Hydrastinin-derivaten [Method for the preparation of hydrastinin derivatives]', Kaiserliches Patentamt, DE274350C.

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., et al. (2021), ‘MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study’, Nature Medicine 27:6, pp. 1025-1033.

Mounteney, J., Griffiths, P., Bo, A., Cunningham, A., Matias, J. and Pirona, A. (2018), ‘Nine reasons why ecstasy is not quite what it used to be’, International Journal of Drug Policy 51, pp. 36-41.

Nair, J. B., Hakes, L., Yazar-Klosinski, B. and Paisner, K. (2021), ‘Fully validated, multi-kilogram cGMP synthesis of MDMA’, ACS Omega 7(1), pp. 900-907.

National Police of the Netherlands (NPNL) (2022), National strategic assessment of drug-related serious and organised crime in the Netherlands 2021, National Police of the Netherlands, Zoetermeer.

National Police of the Netherlands (NPNL) (2024), National survey of drug sites, 2023, National Police of the Netherlands, Zoetermeer.

Nichols, D. E. (1986), ‘Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens’, Journal of Psychoactive Drugs 18(4), pp. 305-313.

Nichols, D. E. (2022), ‘Entactogens: How the name for a novel class of psychoactive agents originated’, Frontiers in Psychiatry 13, p. 863088, doi:10.3389/fpsyt.2022.863088.

Nooijens, S. (2023), 'Hier ligt de grootste drugsput van Nederland: "Nog nooit gezien dit"', ZuidWest, 30 November.

NOS (2021), 'Drugsbende stuurde 50.000 xtc-pillen naar Vietnam via pakketdiensten', NOS Nieuws, 14 December.

Nuwer, R. (2023), I feel love: MDMA and the quest for connection in a fractured world, Bloomsbury Publishing, New York.

Palamar, J. J. (2023), ‘Tusi: A new ketamine concoction complicating the drug landscape’, The American Journal of Drug and Alcohol Abuse 1(5).

Parrott, A. C. (2013), ‘Human psychobiology of MDMA or 'Ecstasy': An overview of 25 years of empirical research’, Human Psychopharmacology: Clinical and Experimental 28(4), pp. 289-307.

Pascoe, M. J., Radley, S., Simmons, H. T. D. and Measham, F. (2022), ‘The cathinone hydra: Increased cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns’, Drug Science, Policy and Law 8, doi:10.1177/20503245221099209.

Pitts, E. G., Curry, D. W., Hampshire, K. N., Young, M. B. and Howell, L. L. (2018), ‘(±)-MDMA and its enantiomers: potential therapeutic advantages of R (−)-MDMA’, Psychopharmacology 235, pp. 377-392.

Policía Nacional España (2022), 'Detalle nota de prensa: Interceptado por primera vez un cargamento marítimo de MDMA desde Europa con destino a Sudamérica', 10 December.

Politie (2021), 'Press release: Zes verdachten opgepakt voor versturen van XTC met postpakketten', 14 December.

Quireyns, M., Boogaerts, T., Wichelen, N., Covaci, A. and Nuijs, A. L. N. (2023), ‘Estimating the size of drug markets in selected European cities using wastewater-derived data on drug and drug metabolite residues’, EMCDDA contract CT.22.SAS.0048.1.0.

Reardon, S. (2024), ‘FDA rejects ecstasy as a therapy: what’s next for psychedelics?’, Nature, News Article, 13 August 2024.

Roxburgh, A., Sam, B., Kriikku, P., Mounteney, J., Castanera, A., Dias, M. and Giraudon, I. (2021), ‘Trends in MDMA‐related mortality across four countries’, Addiction 116(11), pp. 3094-3103.

Sanen, S. (2021), 'Van flessen cava tot knuffelberen: Synthetische drugs versturen via postpakketten is “booming business" in ons land', RVT NWS, 21 December.

Shuldiner, H. (2022), 'Chile receiving synthetic drugs galore from Netherlands', InSight Crime, 2022.

Shulgin, A. and Shulgin, A. (1991), PIHKAL: A chemical love story, Transform Press.

Soudijn, M. R. J. and Vijlbrief, M. F. J. (2011), ‘The production of ecstasy in the Netherlands’, in Smith, C. J., Zhang, S. X. and Barbaret, R. (editors), Routledge Handbook of International Criminology, Routledge, Abingdon, United Kingdom, pp. 248-259.

State Commission on MDMA (2024), Report of the State Commission on MDMA: Beyond Ecstasy, Government of the Netherlands, Ministry of Health, Welfare and Sport, State Commission on MDMA, The Hague.

ter Laak, T. and Mehlbaum, S. (2022), Inventarisatie drugsproductieafval, KWR, Nieuwegein.

Therapeutic Groups Administration (2023), MDMA and psilocybin hub.

Tops, P., Valkenhoef, J., Torre, E. and Spijk, L. (2018), ‘Waar een klein land groot in kan zijn’, Nederland en synthetische drugs in de afgelopen 50 jaar, Boom, Den Haag, the Netherlands.

United Nations (1986), Amendment to the 1971 Convention on Psychotropic Substances: Placement of 3,4-Methylenedioxymethamphetamine (MDMA) in Schedule I, United Nations.

United Nations Office on Drugs and Crime (UNODC) (2008), World Drug Report 2008, United Nations Office on Drugs and Crime, Vienna.

United Nations Office on Drugs and Crime (UNODC) (2020), 'Brazil: Emergence of 'ecstasy' manufacture in clandestine laboratories', August 2020.

United Nations Office on Drugs and Crime (UNODC) (2021), Synthetic drugs and new psychoactive substances in Latin America and the Caribbean 2021, United Nations Office on Drugs and Crime, Vienna.

United Nations Office on Drugs and Crime (UNODC) (2022), World Drug Report 2022, United Nations Office on Drugs and Crime, Vienna.

United Nations Office on Drugs and Crime (UNODC) (2023), World drug report 2023, United Nations Office on Drugs and Crime, Vienna.

United Nations Office on Drugs and Crime (UNODC) (2024), World drug report 2024, United Nations Office on Drugs and Crime, Vienna.

United States Department of Justice (2001), ‘2C-B (Nexus) reappears on the club drug scene’, Information Bulletin Product(2001-L0424-002).

US-CHINA Economic Security Review Commission (2017), ‘Fentanyl: China’s deadly export to the United States’.

US-CHINA Economic Security Review Commission (2018), ‘Fentanyl flows from China: An update since 2017’.

van de Kasteele, T. (2022), 'Halsterse drugsput bevat 37 zeecontainers vervuilde grond, maar wie gaat de bodemsanering betalen?', BN De Stem, 29 January.

van Nuijs, A. L., Mougel, J. F., Tarcomnicu, I., Bervoets, L., Blust, R., Jorens, P. G., Neels, H. and Covaci, A. (2011), ‘Sewage epidemiology: a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium’, Environment International 37, pp. 612-621.

Vidal Giné, C., Navarro López, J., Ventura Vilamala, M., Vega Moreno, B. and Bustos Vargas, A. (2022), MDMA, amphetamine and cocaine markets in Spain: Seen through a drug checking service, Fundación Acción, Bienestar y Desarrollo, Barcelona.

Wright, G. (2024), ‘US expert panel votes against MDMA therapy’, BBC News, 5 June 2024.

Vrolijk, R. Q., Measham, F., Quesada, A., Luf, A., Schori, D., Radley, S. and Ventura, M. (2022), ‘Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021’, Drugs, Habits and Social Policy 23(3), pp. 207-219.